Graf Akcie OFIX (Orthofix Medical Inc). Diskuze k akciím OFIX. Aktuální informace OFIX.

Základní informace o společnosti Orthofix Medical Inc (Akcie OFIX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 714.48M
Hodnota podniku (EV) 700.44M
Tržby 455.591M
EBITDA 17.999M
Zisk -8.12
Růst v tržbách Q/Q 65.99 %
Růst v tržbách Y/Y 10.33 %
P/E (Cena vůči ziskům) N/A
Forward P/E 29.82
EV/Sales 1.54
EV/EBITDA 38.92
EV/EBIT 60.37
PEG 2.85
Price/Sales 1.57
P/FCF 26.57
Price/Book 2.00
Účetní hodnota na akcii 18.16
Hotovost na akcii 4.93
FCF vůči ceně 3.76 %
Počet zaměstnanců 1,036
Tržba na zaměstnance 439.760k
Profit margin 0.62 %
Operating margin 2.03 %
Gross margin 74.94 %
EBIT margin 2.55 %
EBITDA margin 3.95 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -154.24 %
EPS - Očekávaný růst příští rok -51.61 %
Return on assets -1.58 %
Return on equity -2.27 %
ROIC 0.41 %
ROCE 2.76 %
Dluhy/Equity 0.47
Čistý dluh/EBITDA -14.52
Current ratio 3.17
Quick Ratio 2.17
Volatilita 3.40
Beta 1.07
RSI 34.58
Cílová cena analytiků 46
Známka akcie (dle analytiků) 2.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 19.695M
Procento shortovaných akcií 2.47 %
Short ratio 3.31 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1992
Země United States

Finanční výsledky akcie OFIX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$459.955$453.042$433.823$409.788$396.489$402.277
Cost Of Goods Sold$100.607$96.628$93.037$87.853$86.525$98.912
Gross Profit$359.348$356.414$340.786$321.935$309.964$303.365
Research And Development Expenses$34.637$33.218$29.7$28.803$26.389$24.994
SG&A Expenses$309.283$288.778$270.275$257.696$265.237$245.621
Other Operating Income Or Expenses$-34.212$-4.324-$-14.369$-9.083$-15.614
Operating Expenses$478.739$422.948$393.012$388.721$387.234$385.141
Operating Income$-18.784$30.094$40.811$21.067$9.255$17.136
Total Non-Operating Income/Expense$-8.265$-7.209$-4.42$-2.043$-0.748$-4.68
Pre-Tax Income$-27.049$22.885$36.391$19.024$8.507$12.456
Income Taxes$1.413$9.074$29.1$15.527$10.849$16.2
Income After Taxes$-28.462$13.811$7.291$3.497$-2.342$-3.744
Other Income------
Income From Continuous Operations$-28.462$13.811$7.291$3.497$-2.342$-3.744
Income From Discontinued Operations--$-1.068$-0.441$-0.467$-4.793
Net Income$-28.462$13.811$6.223$3.056$-2.809$-8.537
EBITDA$9.693$49.777$62.647$43.477$31.93$43.635
EBIT$-18.784$30.094$40.811$21.067$9.255$17.136
Basic Shares Outstanding191818181918
Shares Outstanding191918181918
Basic EPS$-1.51$0.73$0.34$0.17$-0.15$-0.46
EPS - Earnings Per Share$-1.51$0.72$0.34$0.17$-0.15$-0.46
# 2020 2019 2018 2017 2016 2015
Current Ratio3.06962.84773.17112.32952.58883.296
Long-term Debt / Capital0.0593-----
Debt/Equity Ratio0.064-----
Gross Margin78.126878.671378.554278.561478.177275.412
Operating Margin-4.08396.64279.40735.1412.33424.2597
EBIT Margin-4.08396.64279.40735.1412.33424.2597
EBITDA Margin2.107410.987314.440710.60968.053210.847
Pre-Tax Profit Margin-5.88085.05148.38844.64242.14563.0964
Net Profit Margin-6.1883.04851.43450.7458-0.7085-2.1222
Asset Turnover0.9280.97091.07021.10130.99071.0237
Inventory Turnover Ratio1.2211.25741.14391.38691.50311.6528
Receiveable Turnover5.29875.82716.83867.08396.62596.5562
Days Sales In Receivables68.884662.63853.373251.525555.086655.6723
ROE - Return On Equity-8.68724.11782.45811.3273-0.8067-1.2496
Return On Tangible Equity-14.06826.54243.13481.7273-1.0119-1.5671
ROA - Return On Assets-5.74272.95971.79870.9398-0.5852-0.9528
ROI - Return On Investment-8.17224.11782.45811.3273-0.8067-1.2496
Book Value Per Share17.222918.051516.226714.778815.557916.0995
Operating Cash Flow Per Share-0.94520.5331-1.0930.8794-0.4515-0.8139
Free Cash Flow Per Share-1.28170.5048-0.97011.181-0.6659-1.7911